AnalystsWilliam MaughanWilliam Maughan's Stock Forecasts
AnalystsWilliam Maughan
Sectors:
Industries:
Analyst Ranking
Top 7%
#316 out of 4937 analysts
Average Return
+80.08%
Win Rate
57%13 out of 23
Risk vs Reward
Poor
Good
William Maughan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Biontech SeBNTX | +378.07% | $18.97 | $90.69 | 2019-11-04 - 2020-11-04 | Strong Buy |
Harpoon Therapeutics IncHARP | +326.11% | $5.40 | $23.01 | 2023-09-14 - 2024-03-08 | Strong Buy |
Y Mabs Therapeutics IncYMAB | +224.55% | $5.01 | $16.26 | 2023-03-31 - 2024-03-28 | Strong Buy |
Harpoon Therapeutics IncHARP | +206.80% | $7.50 | $23.01 | 2023-04-03 - 2024-03-08 | Strong Buy |
Biontech SeBNTX | +183.42% | $91.60 | $259.61 | 2020-07-21 - 2021-07-21 | Strong Buy |
William Maughan Analyst Color
Get additional color on William Maughan's coverage of popular stocks
William Maughan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biontech SeBNTX | 13 | Strong Buy | $171.44 | +51.86% | Maintains | 8 months ago |
Harpoon Therapeutics IncHARP | 3 | Strong Buy | $40.00 | N/A | Maintains | 2 years ago |
Y Mabs Therapeutics IncYMAB | 2 | Strong Buy | $18.00 | N/A | Maintains | 2 years ago |
Xencor IncXNCR | 2 | Strong Buy | $42.00 | N/A | Maintains | 2 years ago |
Neurogene IncNGNE | 2 | Hold | $5.00 | N/A | Downgrades | 3 years ago |
Olema Pharmaceuticals IncOLMA | 1 | Strong Buy | $16.00 | N/A | Assumes | 3 years ago |
Bicycle Therapeutics PLCBCYC | 1 | Strong Buy | $60.00 | N/A | Assumes | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.